However, given that wild-type APP plays crucial physiological roles in CNS development, off-targeted altering of the amounts of wild-type APP (only one or two bases difference with mutant pathogenic APP in coding sequence) is probably to worsen AD symptoms [5]. This evidence concerns the gene APP and Alzheimer disease.